Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in June 2021:
Jefferies Virtual Healthcare Conference
Dates: Tuesday, June 1 – Friday June 4, 2021
Presentation date: Tuesday, June 1, 2021
Time: 11:00 a.m. EST / 5:00 p.m. CET
Presenter: Filippo Petti, CEO
Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website.
William Blair & Company Annual Growth Stock Conference
Dates: Tuesday, June 1 – Thursday, June 3, 2021
Presentation date: Wednesday, June 2, 2021
Time: 11:00 a.m. EST / 5:00 p.m. CET
Presenter: Filippo Petti, CEO
Webcast: An archived webcast of the presentation will be available in the Events section of the Celyad Oncology website
JMP Securities Life Sciences Conference
Dates: Wednesday, June 16 – Thursday, June 17, 2021
Presentation date: Thursday, June 17, 2021
Time: 11:30 a.m. EST / 5:30 p.m. CET
Presenter: Filippo Petti, CEO
Kepler Cheuvreux Digital Life Science Day
Date: June 22, 2021
